404 related articles for article (PubMed ID: 16008163)
21. CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease.
Elbaz A; Levecque C; Clavel J; Vidal JS; Richard F; Amouyel P; Alpérovitch A; Chartier-Harlin MC; Tzourio C
Ann Neurol; 2004 Mar; 55(3):430-4. PubMed ID: 14991823
[TBL] [Abstract][Full Text] [Related]
22. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
[TBL] [Abstract][Full Text] [Related]
23. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease.
Gorell JM; Johnson CC; Rybicki BA; Peterson EL; Kortsha GX; Brown GG; Richardson RJ
Neurotoxicology; 1999; 20(2-3):239-47. PubMed ID: 10385887
[TBL] [Abstract][Full Text] [Related]
24. Pesticides and risk of Parkinson disease: a population-based case-control study.
Firestone JA; Smith-Weller T; Franklin G; Swanson P; Longstreth WT; Checkoway H
Arch Neurol; 2005 Jan; 62(1):91-5. PubMed ID: 15642854
[TBL] [Abstract][Full Text] [Related]
25. 192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer.
Oztürk O; Kağnici OF; Oztürk T; Durak H; Tüzüner BM; Kisakesen HI; Cakalir C; Isbir T
Anticancer Res; 2009 Oct; 29(10):4041-6. PubMed ID: 19846948
[TBL] [Abstract][Full Text] [Related]
26. Paraoxonase1 polymorphism Leu-Met55 is associated with cerebral infarction in Japanese population.
Ueno T; Shimazaki E; Matsumoto T; Watanabe H; Tsunemi A; Takahashi Y; Mori M; Hamano R; Fujioka T; Soma M; Matsumoto K; Kanmatsuse K
Med Sci Monit; 2003 Jun; 9(6):CR208-12. PubMed ID: 12824947
[TBL] [Abstract][Full Text] [Related]
27. Role of familial, environmental and occupational factors in the development of Parkinson's disease.
Das K; Ghosh M; Nag C; Nandy SP; Banerjee M; Datta M; Devi G; Chaterjee G
Neurodegener Dis; 2011; 8(5):345-51. PubMed ID: 21346317
[TBL] [Abstract][Full Text] [Related]
28. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis.
Morahan JM; Yu B; Trent RJ; Pamphlett R
Neurotoxicology; 2007 May; 28(3):532-40. PubMed ID: 17204329
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.
Droździk M; Białecka M; Myśliwiec K; Honczarenko K; Stankiewicz J; Sych Z
Pharmacogenetics; 2003 May; 13(5):259-63. PubMed ID: 12724617
[TBL] [Abstract][Full Text] [Related]
30. Human paraoxonase gene polymorphisms and coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
[TBL] [Abstract][Full Text] [Related]
31. A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy.
Smargiassi A; Mutti A; De Rosa A; De Palma G; Negrotti A; Calzetti S
Neurotoxicology; 1998; 19(4-5):709-12. PubMed ID: 9745932
[TBL] [Abstract][Full Text] [Related]
32. Investigation of PON1 192 and PON1 55 polymorphisms in ovarian cancer patients in Turkish population.
Arpaci A; Görmüs U; Dalan B; Berkman S; Isbir T
In Vivo; 2009; 23(3):421-4. PubMed ID: 19454508
[TBL] [Abstract][Full Text] [Related]
33. [The EcoR V polymorphism of human monoamine oxidase A is not associated with idiopathic Parkinson's disease in a Shanghai Han population].
Xie H; Wang X; Hao Y; Tang G; Xu L; Wu Q; Chen L; Ren D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):329-31. PubMed ID: 12170473
[TBL] [Abstract][Full Text] [Related]
34. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
[TBL] [Abstract][Full Text] [Related]
35. Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy.
Nuti A; Ceravolo R; Dell'Agnello G; Gambaccini G; Bellini G; Kiferle L; Rossi C; Logi C; Bonuccelli U
Parkinsonism Relat Disord; 2004 Dec; 10(8):481-5. PubMed ID: 15542008
[TBL] [Abstract][Full Text] [Related]
36. [Genetic polymorphisms of cytochrome P450 1A1 and susceptibility of early-onset Parkinson's disease].
Liu P; Liu Z; Shao M; Chen B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):283-5. PubMed ID: 11484167
[TBL] [Abstract][Full Text] [Related]
37. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
Ozkök E; Aydin M; Babalik E; Ozbek Z; Ince N; Kara I
Med Sci Monit; 2008 Oct; 14(10):CR536-42. PubMed ID: 18830194
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and etiology of Parkinson's disease: a review of the evidence.
Wirdefeldt K; Adami HO; Cole P; Trichopoulos D; Mandel J
Eur J Epidemiol; 2011 Jun; 26 Suppl 1():S1-58. PubMed ID: 21626386
[TBL] [Abstract][Full Text] [Related]
39. [Gln192Arg polymorphism of the paraoxonase-1 gene is not associated with Alzheimer's disease in Chinese].
Shi JJ; Zhang SZ; Ma C; Tang MN; Liu XH; Wang YC; Han HY; Guo YB; Feng RM; Miao GD
Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):371-4. PubMed ID: 15090300
[TBL] [Abstract][Full Text] [Related]
40. [Risk factors for Parkinson disease: an epidemiologic study].
Pereira D; Garrett C
Acta Med Port; 2010; 23(1):15-24. PubMed ID: 20353703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
